Estimates of benefits and harms of prophylactic use of aspirin in the general population
Jack Cuzick(Queen Mary University of London), Asad Umar(Center for Cancer Research), John Burn(Newcastle University), Mangesh A. Thorat, Leslie G. Ford, Eric J. Jacobs(American Cancer Society), Cristina Bosetti(Joint Research Centre), Frank L. Meyskens(University of California, Irvine), Powel H. Brown(The University of Texas MD Anderson Cancer Center), Carlo La Vecchia(University of Milan), Matthew Law(UNSW Sydney), Nancy R. Cook(Brigham and Women's Hospital), Janusz Jankowski(University College London), H.-J. Senn(Breast Center), Peter M. Rothwell(UK Dementia Research Institute)
Cited by 388
Related Papers
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
|New England Journal of Medicine|2002|3.6k
Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular Disease
|New England Journal of Medicine|1996|2.4k
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events
|Circulation|2003|2.3k
Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction
|Circulation|2007|2.1k